Readnour Robin Shane's Form 4 filing
AN2 Therapeutics, Inc. (ANTX) · filed Dec 10, 2024
- Accession no.
- 0000950170-24-135150
- Filed
- Dec 10, 2024
- Trade date
- Dec 6-10, 2024
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 6 non-derivative transactions. Open-market purchases total $86.8K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Readnour Robin ShaneCIK 0001914883 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 6, 2024 | Common Stock | PPurchaseAcquired | +12,711 | $1.45F1 | +$18,430.95 | 564,999 | Indirect | |
| Dec 6, 2024 | Common Stock | PPurchaseAcquired | +6,517 | $1.45F4 | +$9,449.65 | 629,090 | Indirect | |
| Dec 9, 2024 | Common Stock | PPurchaseAcquired | +12,289 | $1.43F6 | +$17,573.27 | 577,288 | Indirect | |
| Dec 9, 2024 | Common Stock | PPurchaseAcquired | +18,483 | $1.43F7 | +$26,430.69 | 647,573 | Indirect | |
| Dec 10, 2024 | Common Stock | PPurchaseAcquired | +5,000 | $1.49F8 | +$7,450 | 582,288 | Indirect | |
| Dec 10, 2024 | Common Stock | PPurchaseAcquired | +5,000 | $1.49F9 | +$7,450 | 652,573 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
This price represents the weighted average purchase price for multiple transactions reported on this line. The prices of the transactions reported on this line ranged from $1.40 to $1.45 per share. Upon request by the Commission staff, the issuer or a security holder of the issuer, the reporting person will undertake to provide full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.
- F4
This price represents the weighted average purchase price for multiple transactions reported on this line. The prices of the transactions reported on this line ranged from $1.435 to $1.45 per share. Upon request by the Commission staff, the issuer or a security holder of the issuer, the reporting person will undertake to provide full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.
- F6
This price represents the weighted average purchase price for multiple transactions reported on this line. The prices of the transactions reported on this line ranged from $1.405 to $1.45 per share. Upon request by the Commission staff, the issuer or a security holder of the issuer, the reporting person will undertake to provide full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.
- F7
This price represents the weighted average purchase price for multiple transactions reported on this line. The prices of the transactions reported on this line ranged from $1.41 to $1.45 per share. Upon request by the Commission staff, the issuer or a security holder of the issuer, the reporting person will undertake to provide full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.
- F8
This price represents the weighted average purchase price for multiple transactions reported on this line. The prices of the transactions reported on this line ranged from $1.44 to $1.50 per share. Upon request by the Commission staff, the issuer or a security holder of the issuer, the reporting person will undertake to provide full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.
- F9
This price represents the weighted average purchase price for multiple transactions reported on this line. The prices of the transactions reported on this line ranged from $1.46 to $1.50 per share. Upon request by the Commission staff, the issuer or a security holder of the issuer, the reporting person will undertake to provide full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.